Advancing bispecific discovery programs towards clinical success using GS Discovery® and bYlok®
49:58
Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets
43:28
Strategies for Mitigating the Unpredictability of Fc-Mediated Functions in Antibody Development
52:50
Exploring TCR-Epitope Prediction Tools: Insights And Pitfalls
54:39
Innovative Technologies for Antibody Discovery, Transforming Hit Generation & Lead Characterization
46:00
Harnessing the power of ADCs: How the Signals™ Research Suite advances multi-modal drug development
41:26
Rapid Generation of Bispecific Antibodies through Engineered Reversibly Inhibitable SpyCatcher.
37:08
Antibody discovery at the edge of impossible
27:55